The FDA approved mirikizumab-mrkz (Omvoh, Eli Lilly) infusion for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
OCTOBER 27, 2023
FDA Approves Omvoh for Adults With Moderately to Severely Active Ulcerative Colitis
By PPN Staff